36,287 results match your criteria: "Mammography in Breast Cancer"
Can Assoc Radiol J
December 2024
Department of Radiology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Breast Imaging-Reporting and Data System (BI-RADS) density scores have been included in screening mammography reports in BC since 2018. Despite these density scores being present in screening mammography reports for numerous years, there remains insufficient evidence to guide supplemental testing for patients with dense breasts. The primary objective of this study was to evaluate how primary care providers in Canada utilize BI-RADS density scores reported on normal screening mammograms of average risk, asymptomatic patients in their clinical practice.
View Article and Find Full Text PDFEur Radiol
December 2024
Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands.
Objectives: Quality control in breast cancer screening programmes has been subject of several studies. However, less is known about the clinical diagnostic work-up in recalled women with a suspicious finding at screening mammography. The current study focuses on interhospital differences in diagnostic work-up strategies.
View Article and Find Full Text PDFEur Radiol
December 2024
Radiology Diagnostics, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
Objectives: Limited understanding exists regarding non-detected cancers in digital breast tomosynthesis (DBT) screening. This study aims to classify non-detected cancers into true or false negatives, compare them with true positives, and analyze reasons for non-detection.
Materials And Methods: Conducted between 2010 and 2015, the prospective single-center Malmö Breast Tomosynthesis Screening Trial (MBTST) compared one-view DBT and two-view digital mammography (DM).
Background: Clinical breast exam (CBE) by outreach healthcare workers (HCW) may help downstage breast cancer in resource-limited areas where mammography may not be feasible. We evaluated the effectiveness of a pilot cascade-model training programme for HCWs in remote areas of Pakistan.
Methods: The training programme comprised three phases.
J Med Imaging (Bellingham)
January 2025
Siemens Healthineers AG, Forchheim, Germany.
Purpose: Digital breast tomosynthesis (DBT) has been introduced more than a decade ago. Studies have shown higher breast cancer detection rates and lower recall rates, and it has become an established imaging method in diagnostic settings. However, full-field digital mammography (FFDM) remains the most common imaging modality for screening in many countries, as it delivers high-resolution planar images of the breast.
View Article and Find Full Text PDFBackground: Breast density is a strong predictor of breast cancer. However, the difference in risk between breast density categories C and D remains inadequately explored. Given the low occurrence of extremely dense breasts, this investigation is crucial because it may lead to modifications in screening techniques for those with these conditions.
View Article and Find Full Text PDFSyst Rev
December 2024
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Objective: This systematic review update synthesized recent evidence on the benefits and harms of breast cancer screening in women aged ≥ 40 years and aims to inform the Canadian Task Force on Preventive Health Care's (CTFPHC) guideline update.
Methods: We searched Ovid MEDLINE® ALL, Embase Classic + Embase and Cochrane Central Register of Controlled Trials to update our searches to July 8, 2023. Search results for observational studies were limited to publication dates from 2014 to capture more relevant studies.
J Surg Oncol
December 2024
Department of Surgery, Morehouse School of Medicine, Atlanta, Georgia, USA.
This article addresses the persistent disparities in breast cancer outcomes across different racial, ethnic, and socioeconomic groups despite advancements in diagnosis and treatment. The disparities are rooted in various factors, including access to care, socioeconomic status, and cultural barriers. The article emphasizes the need for targeted interventions, such as expanding insurance coverage, mobile mammography units, and culturally tailored outreach programs to promote health equity.
View Article and Find Full Text PDFQuant Imaging Med Surg
December 2024
Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Background: Under the Breast Imaging Reporting and Data System (BI-RADS), category 4 lesions have a high probability of malignancy. This study sought to investigate the efficacy of a model that combined the BI-RADS score with the enhancement score and clinical indicators in the diagnosis of BI-RADS 4 lesions based on contrast-enhanced spectral mammography (CESM) in breast cancer patients.
Methods: The data of female patients with BI-RADS scores of 4 who underwent CESM at the Department of Medical Imaging of the Third Affiliated Hospital of Soochow University from January 2018 to July 2023 were retrospectively collected.
Quant Imaging Med Surg
December 2024
Department of Radiology, Shenzhen People's Hospital, Shenzhen, China.
Background: The classification of Breast Imaging Reporting and Data System (BI-RADS) category 4A lesions in mammography is complicated by subjective interpretations and unclear criteria, which can lead to potential misclassifications and unnecessary biopsies. Thus, more accurate assessment methods need to be developed. This study aimed to improve the classification prediction of BI-RADS 4A positive lesions in mammography by combining deep learning (DL) technology with relevant clinical factors.
View Article and Find Full Text PDFIndian J Radiol Imaging
January 2025
Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences, New Delhi, India.
Synthesized mammography (SM) refers to two-dimensional (2D) images derived from the digital breast tomosynthesis (DBT) data. It can reduce the radiation dose and scan duration when compared with conventional full-field digital mammography (FFDM) plus tomosynthesis. To compare the diagnostic performance of 2D FFDM with synthetic mammograms obtained from DBT in a diagnostic population.
View Article and Find Full Text PDFHong Kong Med J
December 2024
Department of Imaging and Interventional Radiology, Prince of Wales Hospital, Hong Kong SAR, China.
Introduction: Research concerning artificial intelligence in breast cancer detection has primarily focused on population screening. However, Hong Kong lacks a population-based screening programme. This study aimed to evaluate the potential of artificial intelligence-based computer-assisted diagnosis (AI-CAD) program in symptomatic clinics in Hong Kong and analyse the impact of radio-pathological breast cancer phenotype on AI-CAD performance.
View Article and Find Full Text PDFBMC Med Imaging
December 2024
Department of Electrical Engineering and Computer Science, Texas A&M University-Kingsville, Kingsville, 78363, Texas, USA.
Background: Mammography for the diagnosis of early breast cancer (BC) relies heavily on the identification of breast masses. However, in the early stages, it might be challenging to ascertain whether a breast mass is benign or malignant. Consequently, many deep learning (DL)-based computer-aided diagnosis (CAD) approaches for BC classification have been developed.
View Article and Find Full Text PDFBr J Cancer
December 2024
Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Background: Mammography has poor sensitivity in dense breast tissue. Retrospective studies suggest that Molecular Breast Imaging (MBI), has superior diagnostic accuracy to mammography in women with very dense breast tissue. Women's perspectives of MBI are unknown, but are crucial to understanding the feasibility of, and routes to, adoption into practice.
View Article and Find Full Text PDFDiscov Oncol
December 2024
Department of Community and Family Medicine, All India Institute of Medical Sciences (AIIMS), Jharkhand, Deoghar, India.
Objective: Recently, the integration of Artificial Intelligence (AI) has significantly enhanced the diagnostic accuracy in breast cancer screening. This study aims to deliver an extensive review of the advancements in AI for breast cancer diagnosis and prognosis through a bibliometric analysis.
Methodology: Therefore, this study gathered pertinent peer-reviewed research articles from the Scopus database, spanning the years 2000 to 2024.
J Breast Imaging
December 2024
Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Molecular breast imaging (MBI) is a functional imaging modality that utilizes technetium 99m sestamibi radiotracer uptake to evaluate the biology of breast tumors. Molecular breast imaging can be a useful tool for supplemental screening of women with dense breasts, for breast cancer diagnosis and staging, and for evaluation of treatment response in patients with breast cancer undergoing neoadjuvant systemic therapy. In addition, MBI is useful in problem-solving when mammography and US imaging are insufficient to arrive at a definite diagnosis and for patients who cannot undergo breast MRI.
View Article and Find Full Text PDFComput Biol Med
December 2024
Babeş-Bolyai University, Mihail Kogălniceanu 1, Cluj-Napoca, 400084, Cluj, Romania.
According to the World Health Organization, breast cancer becomes fatal only if it spreads throughout the body. Therefore, regular screening is essential. Whilst mammography is the most frequently used technique, its interpretation can be challenging and time-consuming.
View Article and Find Full Text PDFUltrasound Q
March 2025
Department of General Surgery, Post Graduate Institute of Medical Sciences and Research, Chandigarh, India.
Mucinous carcinomas are a rare type of invasive breast carcinoma characterized by large quantities of extracellular mucin on histopathological examination. These tumors can be easily missed or misdiagnosed. Due to large quantities of mucin, these tumors are presumed to be "soft" masses.
View Article and Find Full Text PDFCancer Med
December 2024
Division of Public Health, Department of Family and Preventive Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Background: Annual or biennial breast cancer screenings are recommended for women 40 and older. Women residing in rural areas have worse breast cancer survival rates than urban women, but no study has focused on rural versus urban residence in Utah regarding breast cancer screening and mortality.
Methods: Cases (n = 14,516) were women aged > 39 diagnosed with a first primary invasive breast cancer between 1998 and 2017 in Utah.
Epidemiol Prev
December 2024
Istituto per lo Studio e la Prevenzione Oncologica, Firenze.
The Social Report (SR) is a form of measurement and reporting, transparency, and communication, essential for sharing decisions, activities, and the value an institution generates with stakeholders from a social responsibility perspective. It is a useful tool for screening programmes to understand their objectives and structure, assess their effectiveness, and promote informed participation by citizens and stakeholders.This contribution explores the implementation of the SR in oncological screening programmes - a project conducted in the CCM 2019 Programme 'Guidelines for Social Reporting of Screening Programmes', coordinated by the Institute for Cancer Research, Prevention and Clinical Network (ISPRO) in Tuscany Region in collaboration with the Centre for Oncological Screenings of Reggio Emilia (Emilia-Romagna Region) and the Population Screening Programmes Service of ATS Valpadana (Lombardy Region) - conducted between 2020 and 2022.
View Article and Find Full Text PDFTher Adv Med Oncol
December 2024
Clinic for Gynecology and Obstetrics, University Hospital RWTH Aachen, Aachen, Germany.
Background And Objectives: Breast cancer is the most common cancer in women, with one in eight women suffering from this disease in her lifetime. The implementation of centrally organized mammography screening for women between 50 and 69 years of age was a major step in the direction of early detection. However, the participation rate reaches approximately 50% of the eligible women, one reason being the painful compression of the breast, cited as a major issue for not participating in this very important program.
View Article and Find Full Text PDFFront Oncol
November 2024
Department of Radiological Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Introduction: Breast cancer screening remains pivotal in early detection and intervention. However, disparities persist, particularly among women with disabilities, necessitating a comprehensive understanding of their screening practices. This study aims to investigate breast cancer screening behaviours in Saudi women with disabilities.
View Article and Find Full Text PDFClin Case Rep
December 2024
Division of General Surgery, Department of Surgery Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan.
Sclerosing adenosis (SA) is a subtype of adenosis characterized by proliferative adenosis and stromal sclerosis with distortion of the terminal ductal lobular unit. Although SA is the most prevalent benign breast condition among middle-aged women, it may be associated with a two-fold increase in breast cancer risk. Microscopic findings of ductal carcinoma in situ (DCIS) in a SA (SA-DCIS) may mimic microinvasive carcinoma or even invasive carcinoma, which may result in overtreatment by a breast surgeon.
View Article and Find Full Text PDFCureus
November 2024
Radiodiagnosis, Sri Ramaswamy Memorial Medical College Hospital and Research Centre, Chengalpattu, IND.
Introduction Breast cancer is a significant health concern in India, representing a large portion of all cancers affecting women and ranking as one of the most common cancers overall. Reliable diagnostic tools are essential for accurately predicting malignancy and reducing the need for unnecessary biopsies. A Breast Imaging Reporting and Database System (BI-RADS) 3 designation suggests a low likelihood of cancer, indicating that findings are likely benign.
View Article and Find Full Text PDF